ReviewCurrent atherosclerosis reports2023

The Cardiovascular Risks Associated with Aromatase Inhibitors, Tamoxifen, and GnRH Agonists in Women with Breast Cancer.

Ibrahim Alfaris et al.PubMed ↗Publisher ↗

No numbers read from the abstract.